Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection


Authors: 
Stalin Raj V., Okba Nisreen M. A., Gutierrez-Alvarez Javier, Drabek Dubravka, van Dieren Brenda, Widagdo W., Lamers Mart M., Widjaja Ivy, Fernandez-Delgado Raul, Sola Isabel, Bensaid Albert, Koopmans Marion P., Segalés Joaquim, Osterhaus Albert D. M. E., Bosch Berend Jan, Enjuanes Luis, Haagmans Bart L.
Date of publication: 
Wednesday, 1 August, 2018
Volume: 
4
Issue: 
8
Pages: 
eaas9667
EVAg connections: 
Research funded by EVAg
Related to EVAg product
Published by EVAg partner

This publication has been related to the following 2 product(s) of our catalogue

2 products displayed


Produced by:
ERASMUS-MC
Shipping From:
Rotterdam - NL
Ref-SKU:
011A-02997
Through direct cloning and expression of the variable heavy chains (VHHs) of HCAbs from the bone marrow of MERS-CoV infected dromedaries, MERS-CoV specific VHHs or nanobodies were produced. VHH-83 binds with exceptionally high affinity to the receptor binding domain of the viral spike protein. In vitro, this VHH efficiently blocks virus entry at picomolar concentrations
Unit: 10 µg
Virus name: 


500,00 €
(Cost per access for Academics)


Produced by:
ERASMUS-MC
Shipping From:
Rotterdam - NL
Ref-SKU:
011A-02999
HCAb-83 is a MERS-CoV specific camel/human chimeric heavy chain only antibody (HCAb) - composed of the camel VHH-83 linked to a human Fc domain lacking the CH1 exon Through direct cloning and expression of the variable heavy chains (VHHs) of HCAbs from the bone marrow of MERS-CoV infected dromedaries, MERS-CoV specific VHHs or nanobodies were produced. VHH-83 binds with exceptionally high affinity to the receptor binding domain of the viral spike protein. In vitro, HCAb-83 efficiently blocks virus entry at picomolar concentrations
Unit: 50 µg
Virus name: 


500,00 €
(Cost per access for Academics)